AUTOANTIBODY PROFILE OF PRIMARY SCLEROSING CHOLANGITIS

被引:29
作者
GUR, H
SHEN, GQ
SUTJITA, M
TERRBERRY, J
ALOSACHIE, I
BARKA, N
LIN, HC
PETER, JB
MERONI, PL
KAPLAN, M
GERSHWIN, E
SHOENFELD, Y
机构
[1] CHAIM SHEBA MED CTR,DEPT MED B,IL-52621 TEL HASHOMER,ISRAEL
[2] CHAIM SHEBA MED CTR,DEPT MED C,IL-52621 TEL HASHOMER,ISRAEL
[3] CHAIM SHEBA MED CTR,RHEUMATOL UNIT,IL-52621 TEL HASHOMER,ISRAEL
[4] SACKLER FAC MED,TEL AVIV,ISRAEL
[5] SPECIALTY LABS INC,SANTA MONICA,CA
[6] UNIV CALIF DAVIS,DIV RHEUMATOL ALLERGY & CLIN IMMUNOL,DAVIS,CA 95616
[7] TUFTS UNIV,SCH MED,GASTROENTEROL SERV,BOSTON,MA 02111
[8] UNIV MILAN,ALLERGY & CLIN IMMUNOL CLIN,MILAN,ITALY
关键词
PRIMARY SCLEROSING CHOLANGITIS; AUTOANTIBODIES; AUTOIMMUNE DISEASES;
D O I
10.1159/000163937
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Primary sclerosing cholangitis (PSC) is a chronic progressive liver disease of unknown etiology. It has been suggested that genetic and immunological factors are important in its pathogenesis. The present study examined the prevalence of 23 different autoantibodies in 25 PSC sera, by ELISA, in order to better define the autoimmune profile of PSC. The results indicate that 88% of PSC patients produced at least 1 autoantibody, and 36% had reactivity to multiple autoantibodies. Moreover, 35% of the PSC patients produced antiendothelial-cell antibodies (AECA) and 75% of the sera contained perinuclear antineutrophil cytoplasmic antibodies (pANCA), detected by indirect immunofluorescence. The prominent ANCA autoantibody was anti-cathepsin-G, demonstrated in 35% of the patients, The multiplicity of the autoantibody profile, revealed in the present study, points to the autoimmune characteristics of PSC. In addition, the association of ANCA and of AECA in PSC may suggest a pathogenic role for these antibodies in PSC.
引用
收藏
页码:76 / 82
页数:7
相关论文
共 39 条
[1]  
ALMER PE, 1993, GUT, V34, P56
[2]   DOWN-REGULATION OF AUTOANTIBODY LEVELS OF CYCLOSPORINE AND BROMOCRIPTINE TREATMENT IN PATIENTS WITH UVEITIS [J].
BLANK, M ;
PALESTINE, A ;
NUSSENBLATT, R ;
SHOENFELD, Y .
CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1990, 54 (01) :87-97
[3]  
BODENHEIMER HC, 1983, HEPATOLOGY, V3, P150
[4]   ASSOCIATION OF PRIMARY SCLEROSING CHOLANGITIS WITH HLA-B8 [J].
CHAPMAN, RW ;
VARGHESE, Z ;
GAUL, R ;
PATEL, G ;
KOKINON, N ;
SHERLOCK, S .
GUT, 1983, 24 (01) :38-41
[5]   EXPRESSION OF HLA-DR ANTIGENS ON BILE-DUCT EPITHELIUM IN PRIMARY SCLEROSING CHOLANGITIS [J].
CHAPMAN, RW ;
KELLY, PMA ;
HERYET, A ;
JEWELL, DP ;
FLEMING, KA .
GUT, 1988, 29 (04) :422-427
[6]   SERUM AUTOANTIBODIES, ULCERATIVE-COLITIS AND PRIMARY SCLEROSING CHOLANGITIS [J].
CHAPMAN, RW ;
COTTONE, M ;
SELBY, WS ;
SHEPHERD, HA ;
SHERLOCK, S ;
JEWELL, DP .
GUT, 1986, 27 (01) :86-91
[8]   PRIMARY SCLEROSING CHOLANGITIS - A REVIEW OF ITS CLINICAL-FEATURES, CHOLANGIOGRAPHY, AND HEPATIC HISTOLOGY [J].
CHAPMAN, RWG ;
ARBORGH, BAM ;
RHODES, JM ;
SUMMERFIELD, JA ;
DICK, R ;
SCHEUER, PJ ;
SHERLOCK, S .
GUT, 1980, 21 (10) :870-877
[9]   PRESENCE OF COMPLEMENT-FIXING ANTI-ENDOTHELIAL CELL ANTIBODIES IN SYSTEMIC LUPUS-ERYTHEMATOSUS [J].
CINES, DB ;
LYSS, AP ;
REEBER, M ;
BINA, M ;
DEHORATIUS, RJ .
JOURNAL OF CLINICAL INVESTIGATION, 1984, 73 (03) :611-625
[10]   DUAL ASSOCIATION OF HLA DR2 AND DR3 WITH PRIMARY SCLEROSING CHOLANGITIS [J].
DONALDSON, PT ;
FARRANT, JM ;
WILKINSON, ML ;
HAYLLAR, K ;
PORTMANN, BC ;
WILLIAMS, R .
HEPATOLOGY, 1991, 13 (01) :129-133